Application segmentation of the Rice Cereal for Infants market is divided into three primary use‑cases: weaning, therapeutic and special nutrition. The weaning segment, representing roughly 55 % of total sales, captures infants transitioning from exclusive breastfeeding to solid foods; its volume is driven by the high frequency of daily feeding and the product’s role as a first‑grain staple. The therapeutic segment, accounting for about 25 % of the market, includes formulations enriched with iron, vitamins or pre‑biotics that are prescribed for infants with mild deficiencies or digestive concerns; its growth is linked to pediatric recommendations and reimbursement policies. The special nutrition segment, comprising the remaining 20 %, targets infants with specific health conditions such as allergies or metabolic disorders, where rice cereal is selected for its hypoallergenic profile. Collectively, these application categories define the overall market size and inform the Rice Cereal for Infants segmentation analysis. Demand elasticity within each sub‑segment is influenced by regional weaning practices, healthcare coverage levels, and the prevalence of infant malnutrition, which together shape forecasted growth trajectories.
